Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

OKYO Pharma Ltd has a consensus price target of $6 based on the ratings of 2 analysts. The high is $7 issued by HC Wainwright & Co. on September 23, 2025. The low is $5 issued by B. Riley Securities on December 8, 2025. The 3 most-recent analyst ratings were released by B. Riley Securities, HC Wainwright & Co., and HC Wainwright & Co. on December 8, 2025, September 23, 2025, and May 5, 2025, respectively. With an average price target of $6.33 between B. Riley Securities, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 234.64% upside for OKYO Pharma Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
| Get Alert | |||||
|---|---|---|---|---|---|
| Dec 8, 2025 | 164.19% | 5 | Previous Initiates Current Buy | Get Alert | |
| Sep 23, 2025 | 269.86% | 77 | Previous Buy Current Buy | Get Alert | |
| May 5, 2025 | 269.86% | 77 | Previous Buy Current Buy | Get Alert | |
| Feb 18, 2025 | 269.86% | 77 | Previous Buy Current Buy | Get Alert | |
| Feb 14, 2025 | 269.86% | 77 | Previous Buy Current Buy | Get Alert | |
| Feb 10, 2025 | 269.86% | 77 | Previous Buy Current Buy | Get Alert | |
| Oct 24, 2024 | 269.86% | 77 | Previous Buy Current Buy | Get Alert | |
| Oct 16, 2024 | 269.86% | 77 | Previous Buy Current Buy | Get Alert | |
| Aug 27, 2024 | 269.86% | 77 | Previous Buy Current Buy | Get Alert | |
| Jul 12, 2024 | 269.86% | 77 | Previous Buy Current Buy | Get Alert | |
| Jul 11, 2024 | 269.86% | 77 | Previous Buy Current Buy | Get Alert | |
| Mar 22, 2024 | 269.86% | 67 | Previous Buy Current Buy | Get Alert | |
| Jan 8, 2024 | 164.19% | 45 | Previous Buy Current Buy | Get Alert | |
| Dec 5, 2023 | 111.35% | 44 | Previous Buy Current Buy | Get Alert | |
| Nov 2, 2023 | 111.35% | 4 | Previous Initiates Current Buy | Get Alert |
The latest price target for OKYO Pharma (NASDAQ:OKYO) was reported by B. Riley Securities on December 8, 2025. The analyst firm set a price target for $5.00 expecting OKYO to rise to within 12 months (a possible 164.19% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for OKYO Pharma (NASDAQ:OKYO) was provided by B. Riley Securities, and OKYO Pharma initiated their buy rating.
There is no last upgrade for OKYO Pharma
There is no last downgrade for OKYO Pharma.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OKYO Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OKYO Pharma was filed on December 8, 2025 so you should expect the next rating to be made available sometime around December 8, 2026.
While ratings are subjective and will change, the latest OKYO Pharma (OKYO) rating was a initiated with a price target of $0.00 to $5.00. The current price OKYO Pharma (OKYO) is trading at is $1.89, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.